XML 26 R12.htm IDEA: XBRL DOCUMENT v3.24.2.u1
FAIR VALUE MEASUREMENTS
6 Months Ended
Jun. 26, 2024
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The carrying values of the Company's Cash and cash equivalents, Accounts receivable, net, Accounts payable and Accrued expenses approximate fair value due to the short-term nature of these financial instruments.
The Company's marketable securities were as follows:
June 26
2024
December 27
2023
Held-to-maturity securities$2,574 $68,561 
The Company classified its held-to-maturity securities as Level 1 within the fair value hierarchy. Refer to Note 6, Debt, for additional information relating to the fair value of the Company's outstanding debt instruments.
The Company's held-to-maturity securities were as follows:
June 26, 2024
Amortized CostGross Unrealized GainsGross Unrealized LossesEstimated Fair Value
U.S. Treasuries$2,574 $456 $— $3,030 
As of June 26, 2024, the contractual maturities of held-to-maturity securities were less than 12 months. Any expected credit losses would not be material to the Condensed Consolidated Statements of Income.
A summary of other income (expense) from marketable securities was as follows:
Thirteen Weeks EndedTwenty-Six Weeks Ended
June 26
2024
June 28
2023
June 26
2024
June 28
2023
Income from marketable securities
$90 $126 $625 $621 
Realized gain on sale of equity securities— — — 81 
Total$90 $126 $625 $702 
Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis
Assets and liabilities measured at fair value on a non-recurring basis include long-lived assets, operating lease right-of-use assets and indefinite-lived intangible assets. The Company performs its impairment analysis at least annually or whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges recognized during the thirteen and twenty-six weeks ended June 26, 2024 and June 28, 2023.